Cognitive Behavioral Therapy, Ketamine, and Combination Treatment for Depression: Impressions of Credibility in Participants with Self-Reported Depressive Symptoms-Reference-Cited by-同舟云学术

Cognitive Behavioral Therapy, Ketamine, and Combination Treatment for Depression: Impressions of Credibility in Participants with Self-Reported Depressive Symptoms

Published:2021-04-20 Issue: Volume: Page:1-11
ISSN:0279-1072
Container-title:Journal of Psychoactive Drugs
language:en
Short-container-title:Journal of Psychoactive Drugs

Author:

Earleywine Mitch¹²^ORCID,Altman Brianna R.¹^ORCID,De Leo Joseph²

Affiliation:

1. Department of Psychology, University at Albany, State University of New York, Albany, NY, USA

2. Centre for Compassionate Care, Hamilton, Ontario, Canada

Publisher

Informa UK Limited

Subject

General Psychology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/02791072.2021.1912863

Reference56 articles.

1. Screening for Depression in Well Older Adults: Evaluation of a Short Form of the CES-D

2. The importance of assessing clinical phenomena in Mechanical Turk research.

3. Perceptions of Cognitive-Behavioral Therapy and Antidepressant Medication for Depression After Brief Psychoeducation: Examining Shifts in Attitudes

4. The symptom‐specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta‐analysis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expectancies for Subjective and Antidepressant Effects in Psilocybin Users;Journal of Humanistic Psychology;2023-09-22

2. Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions;Journal of Psychedelic Studies;2022-06-23

3. How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?;Journal of Psychoactive Drugs;2022-03-23

4. A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression;Expert Opinion on Drug Safety;2022-03-14

5. Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression;Journal of Psychoactive Drugs;2022-01-03